Zhang et al. discover that treated with interferon gamma (IFN-γ) can suppress a variety of pancreatic cancer derived CXCL8 and tumor-derived CXCL8 deficiency inhibit the trafficking of M2 TAM (Zhang et al., 2020). Here, IFNG is linked to familial pancreatic carcinoma.